COVID-19 vaccine review starts Dec. 10
Duration of process is not yet known
Share
Tweet
Last updated 12/6/2020 at 8:38pm
Courtesy of pixabay.com
The FDA is considering a vaccine to combat COVID-19. The duration of the review is not yet known but will be open to the public
The FDA is poised to consider a vaccine for COVID-19 on Dec. 10, a medical innovation with the potential power to end the pandemic six to nine months from the approval date.
The duration of that review is not yet known, but the meeting will be ope...
For access to this article please
sign in or
subscribe.
Reader Comments(0)